drugset / Trial / NCT00154258

A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia

NCT00154258

Phase 2 Completed 19 enrolled Novartis
NaSingle-groupOpen-labelTreatment

Summary

Clozapine is an antipsychotic. This open study will evaluate the safety and efficacy of long term treatment of clozapine in patients with treatment-resistant schizophrenia.

Timeline

Start
2001-04
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Clozapine Other / unclassified

Indications